LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
9.93
+0.28 (2.90%)
Feb 4, 2026, 3:04 PM CST

SHE:002644 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
448.67397.89406.04397.85374.94419.96
Trading Asset Securities
---2-32.08
Cash & Short-Term Investments
448.67397.89406.04399.85374.94452.04
Cash Growth
27.60%-2.01%1.55%6.64%-17.06%4.00%
Accounts Receivable
471.41413.57382.65435.88344.8313.31
Other Receivables
21.4145.5950.562.9812.344.58
Receivables
492.82459.17433.15498.87357.14317.89
Inventory
335.85339.99369.72363.26258.83258.33
Prepaid Expenses
-0.040.9---
Other Current Assets
45.4924.7929.064243.7225.89
Total Current Assets
1,3231,2221,2391,3041,0351,054
Property, Plant & Equipment
990.871,0321,0621,0681,0921,110
Long-Term Investments
50.0555.6664.168.6771.6573.6
Goodwill
9.019.019.019.014.474.47
Other Intangible Assets
74.3976.8779.5576.7971.9674.01
Long-Term Deferred Tax Assets
65.7661.8153.6553.9851.1151.31
Long-Term Deferred Charges
2.363.767.6560.890.27
Other Long-Term Assets
8.698.7813.4320.4125.7618.93
Total Assets
2,5242,4702,5282,6062,3522,387
Accounts Payable
267.62213.09310.37314.47214.3300.21
Accrued Expenses
1.1110.2111.4628.869.99.98
Short-Term Debt
101010--19.62
Current Portion of Long-Term Debt
14.3313.9213.8913.414.214.36
Current Portion of Leases
-0.820.80.870.5-
Current Income Taxes Payable
10.1919.0827.4244.7444.2647.14
Current Unearned Revenue
37.2816.0547.0299.9335.919.1
Other Current Liabilities
85.6496.5646.7440.2855.7822.03
Total Current Liabilities
426.17379.73467.69542.54374.84422.44
Long-Term Debt
5.81526.640.3753.1466.55
Long-Term Leases
1.841.051.350.970.81-
Long-Term Unearned Revenue
241.72256.1260.96278.15294.96310.21
Long-Term Deferred Tax Liabilities
2.472.933.073.180.850.88
Total Liabilities
678.01654.81759.67865.21724.59800.08
Common Stock
510.66510.66510.66510.66510.66510.66
Additional Paid-In Capital
337.39337.39337.38352.33343.51343.01
Retained Earnings
972.83940.88896.13854.47758.78726.8
Comprehensive Income & Other
0.980.961.211.61.621.62
Total Common Equity
1,8221,7901,7451,7191,6151,582
Minority Interest
24.0825.0923.0622.1712.925.01
Shareholders' Equity
1,8461,8151,7681,7411,6281,587
Total Liabilities & Equity
2,5242,4702,5282,6062,3522,387
Total Debt
31.9740.7952.6355.668.65100.54
Net Cash (Debt)
416.7357.1353.41344.26306.29351.5
Net Cash Growth
33.47%1.04%2.66%12.39%-12.86%3.33%
Net Cash Per Share
0.820.700.690.670.600.69
Filing Date Shares Outstanding
510.66510.66510.66510.66510.66510.66
Total Common Shares Outstanding
510.66510.66510.66510.66510.66510.66
Working Capital
896.65842.16771.18761.43659.79631.71
Book Value Per Share
3.573.513.423.373.163.10
Tangible Book Value
1,7381,7041,6571,6331,5381,504
Tangible Book Value Per Share
3.403.343.243.203.012.94
Buildings
-945.9938.67933.74927.81906.76
Machinery
-377.02366.31333.01317.82311.68
Construction In Progress
-1.763.3--3.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.